RAHWAY, N.J.--(BUSINESS WIRE)--Nov 1, 2023--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Jannie Oosthuizen, president, Human Health U.S., is scheduled to participate in a fireside chat at the UBS BioPharma Conference on Wednesday. Nov. 8, 2023, ...
SOMERVILLE, Mass., & BUFFALO, N.Y.--(BUSINESS WIRE)--Nov 1, 2023--Generate:Biomedicines and Roswell Park Comprehensive Cancer Center today announced a strategic collaboration to discover and develop chimeric antigen receptor (CAR) T-cell therapies, and armoring technologies, for up ...
LONDON & NEW YORK--(BUSINESS WIRE)--Nov 1, 2023--ViroCell Biologics (“ViroCell” or the “Company”), a specialist contract development and manufacturing organisation (“CDMO”) for cell and gene therapy (CGT) clinical trials, announces that the Company is now able to ...
<p style="TEXT-ALIGN:CENTER">Poster presentation describes the development of SNAP CAR platform technology as a "universal" CAR therapy with the potential to target multiple antigens through combinatorial use of different adaptorsWEXFORD, Pa., Oct. 31, 2023 /PRNewswire/ -- ...
UPPER NYACK, N.Y.--(BUSINESS WIRE)--Oct 31, 2023--The Global Healthy Living Foundation (GHLF) is thrilled to announce the launch of "Informed Immunity: A Guide to Vaccines for the Chronic Illness Community," a groundbreaking podcast dedicated to providing accessible and reliable vaccine ...